Potential Application of Temozolomide in Mesenchymal Stem Cell-Based TRAIL Gene Therapy Against Malignant Glioma
Seong Muk Kim(Catholic University of Korea), Sin‐Soo Jeun(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 55
Related Papers
Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
|Journal of Biomedicine and Biotechnology|2012|114